IRS - Næstved, Slagelse, Ringsted Hospitals (NSR), Research Unit of Medicine (Slagelse)

Medicine & Life Sciences

1. Chronic Obstructive Pulmonary Disease 100%
2. Type 2 Diabetes Mellitus 91%
3. Lung 65%
4. Asthma 49%
5. Lung Neoplasms 46%
6. Denmark 39%
7. Malignant Pleural Effusion 38%
8. Systematic Reviews 38%
9. Cohort Studies 36%
10. Randomized Controlled Trials 36%
11. Dyspnea 36%
12. Hydroxychloroquine 35%
13. Physiologic Monitoring 34%
14. Endoscopic Ultrasound-Guided Fine Needle Aspiration 32%
15. Respiration 32%
16. Pulmonologists 31%
17. empagliflozin 30%
18. Esophagus 29%
19. Inferior Vena Cava 28%
20. Biopsy 27%
21. Pleural Diseases 27%
22. Mortality 26%
23. Singing 26%
24. Bronchoscopy 26%
25. Fine Needle Biopsy 25%
26. Azithromycin 23%
27. Perfusion 23%
28. Confidence Intervals 21%
29. Placebos 21%
30. Neoplasms 20%
31. Thoracoscopy 20%
32. Telerehabilitation 20%
33. Breathing Exercises 19%
34. Adrenal Cortex Hormones 19%
35. Rehabilitation 19%
36. Glucagon-Like Peptide-1 Receptor 19%
37. Hermeneutics 18%
38. Therapeutics 17%
39. Health 17%
40. Non-Small Cell Lung Carcinoma 17%
41. Cardiovascular Diseases 17%
42. Magnetic Resonance Imaging 17%
43. Exercise 16%
44. Systemic Inflammatory Response Syndrome 16%
45. Pleural Effusion 16%
46. Meta-Analysis 15%
47. Coronavirus 15%
48. Diabetes Complications 15%
49. Delivery of Health Care 14%
50. Retrospective Studies 14%
51. Urinary Incontinence 14%
52. Venous Thromboembolism 14%
53. Left Ventricular Function 14%
54. Adrenal Glands 13%
55. Albuminuria 13%
56. Mental Competency 13%
57. Hospitalization 13%
58. Trachea 13%
59. Neoplasm Metastasis 13%
60. Gray Literature 13%
61. Liraglutide 12%
62. Nose 12%
63. Pneumothorax 11%
64. benralizumab 11%
65. Diabetic Cardiomyopathies 11%
66. Pneumonia 11%
67. Needles 11%
68. Endoscopes 11%
69. Hospital Emergency Service 11%
70. Quality of Life 11%
71. Tomography 11%
72. Sodium-Glucose Transport Proteins 11%
73. Pulmonary Blastoma 11%
74. indacaterol 11%
75. Economics 10%
76. Outpatients 10%
77. Epidemiology 10%
78. Fluoroscopy 10%
79. Databases 10%
80. Positron Emission Tomography Computed Tomography 10%
81. Incidence 10%
82. Prospective Studies 10%
83. Income 10%
84. Self-Management 10%
85. Sodium-Glucose Transporter 2 Inhibitors 9%
86. Epithelioid Hemangioendothelioma 9%
87. Glucagon-Like Peptide 1 9%
88. Bronchiectasis 9%
89. trimethyloxamine 9%
90. Pulmonary Medicine 9%
91. tetramethylrhodamine methyl ester 9%
92. fibroblast growth factor 23 9%
93. Obstructive Lung Diseases 9%
94. Omalizumab 9%
95. Silicones 9%
96. Inflammation 9%
97. Pragmatic Clinical Trials 9%
98. Point-of-Care Systems 9%
99. Pleural Empyema 9%
100. Immunoglobulin G4-Related Disease 9%